Active site modification of factor VIIa affects interactions of the protease domain with tissue factor

被引:76
|
作者
Dickinson, CD
Ruf, W
机构
[1] Scripps Res Inst, DEPT IMMUNOL, LA JOLLA, CA 92037 USA
[2] Scripps Res Inst, DEPT VASC BIOL, LA JOLLA, CA 92037 USA
关键词
D O I
10.1074/jbc.272.32.19875
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the initiation of coagulation, tissue factor (TF) allosterically activates the serine protease factor VIIa (VIIa) through specific interactions with protease domain residues. These interactions, and consequently affinity for TF, may be influenced by conformational changes in the protease domain that result from zymogen-enzyme transition or occupancy of the active site by tight binding inhibitors, In functional competition and direct binding analysis, we determined affinities for zymogen and enzyme species of wild-type VII and of mutants at protease domain residues that contact TF. We demonstrate that TF binding is not influenced by zymogen activation, indicating that the protease domain of zymogen and enzyme dock similarly with TF, In contrast, active site occupancy enhanced the affinity for TF by predominantly decreasing the dissociation rate of the TF.VIIa complex. Of the three interface residues studied, only Met(306) played a major role in the inhibitor-induced increase in affinity. Met(306) is also important for transmitting the allosteric changes from TF to the active site, resulting in enhanced catalysis. This study thus provides evidence for a bidirectional conformational interdependence of the interface residue Met(306) and the active site of VIIa.
引用
收藏
页码:19875 / 19879
页数:5
相关论文
共 50 条
  • [21] Factor VIIa tissue factor: Functional importance of protein-membrane interactions
    Morrissey, JH
    Neuenschwander, PF
    Huang, QL
    McCallum, CD
    Su, BX
    Johnson, AE
    THROMBOSIS AND HAEMOSTASIS, 1997, 78 (01) : 112 - 116
  • [22] SUBSTRATES FOR HUMAN FACTOR-VIIA AND FACTOR-VIIA TISSUE FACTOR
    BUTENAS, S
    MANN, KG
    CIRCULATION, 1992, 86 (04) : 816 - 816
  • [23] Internalized factor VIIa and not the active site-inactivated factor VIIa associates with nuclear fraction in fibroblasts.
    Iakhiaev, A
    Pendurthi, U
    Ezban, M
    Rao, LVM
    BLOOD, 2000, 96 (11) : 260A - 260A
  • [24] Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor (vol 272, pg 11863, 1997)
    Sorenson, BB
    Persson, E
    Freskgard, PO
    Kjalke, M
    Ezban, M
    Williams, T
    Rao, LVM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (26) : 16708 - 16708
  • [25] Structural element of factor VIIA required for active site information
    Mizuguchi, J
    Soejima, K
    Yuguchi, M
    Nakagaki, T
    Iwanaga, S
    THROMBOSIS AND HAEMOSTASIS, 1999, : 466 - 466
  • [26] CONTRIBUTION OF COFACTOR RESIDUES TO MACROMOLECULAR SUBSTRATE RECOGNITION BY THE TISSUE FACTOR - FACTOR VIIA PROTEASE COMPLEX
    RUF, W
    MILES, DJ
    REHEMTULLA, A
    EDGINGTON, TS
    FASEB JOURNAL, 1992, 6 (05): : A2051 - A2051
  • [27] SYNTHETIC SUBSTRATES FOR HUMAN FACTOR-VIIA AND FACTOR-VIIA-TISSUE FACTOR
    BUTENAS, S
    RIBARIK, N
    MANN, KG
    BIOCHEMISTRY, 1993, 32 (26) : 6531 - 6538
  • [28] Regulation of factor VIIa and factor VIIa-tissue factor by protein C inhibitor
    Fortenberry, YM
    Cook, AB
    Church, FC
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) : E13 - E14
  • [29] Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages
    Cunningham, MA
    Romas, P
    Hutchinson, P
    Holdsworth, SR
    Tipping, PG
    BLOOD, 1999, 94 (10) : 3413 - 3420
  • [30] The Role of Tissue Factor and Factor VIIa in Hemostasis
    Mackman, Nigel
    ANESTHESIA AND ANALGESIA, 2009, 108 (05): : 1447 - 1452